• Immunofluorescence analysis of GC7901 cells using EPO monoclonal antibody (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.
  • Western blot analysis using EPO monoclonal antibody against HEK293 (1) and EPO-hIgGFc transfected HEK293 (2) cell lysate.

Anti-EPO antibody [4F11] (STJ98039)

SKU:
STJ98039

£139.00 - £336.00
Current Stock:
Host: Mouse
Applications: WB/IF/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Erythropoietin is suitable for use in Western Blot, Immunofluorescence and ELISA research applications.
Clonality: Monoclonal
Clone ID: 4F11
Conjugation: Unconjugated
Isotype: IgG1
Formulation: Liquid in PBS containing 0.03% Sodium Azide, 0.5% BSA, 50% Glycerol.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
IF 1:200-1:1000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: EPO
Gene ID: 2056
Uniprot ID: EPO_HUMAN
Specificity: EPO Monoclonal Antibody detects endogenous levels of EPO protein.
Immunogen: Purified recombinant fragment of human EPO expressed in E. Coli.
Function Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3.
Protein Name Erythropoietin
Epoetin
Database Links Reactome: R-HSA-1234158
Reactome: R-HSA-9006335
Reactome: R-HSA-9027276
Reactome: R-HSA-9027277
Reactome: R-HSA-9027283
Reactome: R-HSA-9027284
Cellular Localisation Secreted
Alternative Antibody Names Anti-Erythropoietin antibody
Anti-Epoetin antibody
Anti-EPO antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance